AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Infant Bacterial Therapeutics

Major Shareholding Notification Dec 22, 2023

3162_iss_2023-12-22_5fb027e6-b9fb-4d2c-98f4-d842d720af49.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

Issuer Infant Bacterial Therapeutics AB

Holder

Keel Capital

Instrument

Instrument Aktie SE0008015259
Before the transaction
Shares Data not given*
Voting rights Data not given*
Transaction
Date 22/12/2023
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 674,171
Directly held voting rights 674,171
Indirectly held voting rights 0
Percentage
Directly held shares 5.0045 %
Directly held voting rights 5.0045 %
Indirectly held voting rights 0 %

Resulting distribution of total

holdings
Percentage of voting
rights:
Number of underlying
shares:
Shares 5.0045 % 674,171
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 5.0045 % 674,171
Published
22/12/2023 10:44
Contact
Name
Gustaf Johansson
Phone
0708393043
Email [email protected]
*Source of information has chosen not to submit the data
CLOSE
PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25

Talk to a Data Expert

Have a question? We'll get back to you promptly.